China Petroleum & Chemical stock has quietly delivered an 83.2% total return over the past 5 years, which raises a simple question for investors who care about price versus fundamentals. The share still screens as undervalued on market multiples, yet the broader valuation checks point to a more mixed picture.
-
A roughly 83.2% gain over 5 years suggests China Petroleum & Chemical has already rewarded patient holders, so fresh buyers may want to ask how much of that progress is already in the price.
-
Recent headlines around strong operational results and expanding low carbon projects can support confidence in future cash generation, while the view that China's oil demand likely peaked in 2025 may limit how generous investors are willing to be on long term valuations.
-
The stock is assessed as a mixed picture rather than a clear bargain or clear overvaluation, with a value score of 3 out of 6 across the broader checks.
The issue now is whether China Petroleum & Chemical's current valuation leaves enough room for attractive future returns after such a strong 5 year run.
Spot 257 high quality undervalued stocks that, like China Petroleum & Chemical, blend solid multi year returns with valuations that still screen as potentially cheap on traditional market multiples.
Does China Petroleum & Chemical Look Undervalued on Earnings?
The P/E ratio suits China Petroleum & Chemical because the stock is widely followed on earnings and dividends and sits in a mature sector where profits are a key anchor for value. The current P/E is about 14.0x, slightly above the Oil and Gas industry average of roughly 13.3x and also above the peer group average of about 9.7x. On raw comparisons the stock does not screen as obviously cheap.
The fair P/E for China Petroleum & Chemical is estimated at about 16.3x, which is higher than the current 14.0x. That gap suggests the market is pricing the stock below what would be expected once its size, earnings profile and risk factors are taken into account. Despite recent headlines around strong H1 2026 results and active capital returns, the current P/E still implies a discount to this more tailored fair multiple.
On the P/E measure, China Petroleum & Chemical stock appears undervalued relative to what the model suggests would be a fair earnings multiple.
See what the numbers say about this price — find out in our valuation breakdown.
The China Petroleum & Chemical Narrative: What Would Justify Today's Price?
Simply Wall St Narratives pick up where the valuation puzzle for China Petroleum & Chemical leaves off and set out the specific assumptions on growth, margins and earnings that would need to hold for the stock to be worth materially more or less than today's price. Each Narrative ties China Petroleum & Chemical's potential fair value to a particular set of catalysts and risks so you can watch over time which version of events comes through. Narratives are available on Simply Wall St's Community page.
Share a narrative on China Petroleum & Chemical's stock to present your own number-driven view on how its recent operational results, dividend and buyback plans, and low carbon projects could shape the story from here.
Be one of the first voices in the Simply Wall St community to set out a clear case and then track how it holds up as new results and CCUS developments come through.
Do you think there's more to the story for China Petroleum & Chemical? Head over to our Community to see what others are saying!
The Bottom Line
China Petroleum & Chemical still screens as undervalued on market multiples, yet the wider checks point to a more balanced picture that does not read as a clear bargain. The key question is whether the current P/E discount is compensation for demand and transition risks, or whether it offers genuine upside if sentiment toward the sector improves. For you as an investor, the crux is how confident you are that earnings and capital returns can support a sustained valuation re rating rather than the stock settling into a lower multiple range.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include 0386.HK .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
